FDA inspection
APL Research Centre-II (Div of Aurobindo Pharma Ltd): FDA inspection ending Jan 10, 2020
FDA inspection 1118582 · No Action Indicated (NAI) · Indrakaran
Key facts
| Inspection ID | 1118582 |
|---|---|
| Firm | APL Research Centre-II (Div of Aurobindo Pharma Ltd) |
| FEI number | 3008765247 |
| Address | & 72 Kandi Mandal, Survey 71 |
| City | Indrakaran |
| Fiscal year | 2020 |
| Inspection end date | Jan 10, 2020 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data